Empagliflozin (Jardiance) – Diabetes & Heart Health

Empagliflozin (Jardiance) – Diabetes/heart failure, commonly called Jardiance, is prescribed to manage type 2 diabetes and improve overall heart health. As an SGLT2 inhibitor, Empagliflozin lowers blood sugar by promoting glucose removal through urine and reduces cardiovascular disease risks effectively. Doctors recommend Jardiance for adults who need reliable diabetes control, maintain a healthy weight, and improve heart function for long-term health.

What is Empagliflozin?

Empagliflozin, sold under the brand name Jardiance, helps adults manage type 2 diabetes by effectively lowering blood sugar levels. It works by helping the kidneys remove excess glucose through urine, effectively lowering blood sugar levels. Beyond controlling diabetes, Empagliflozin reduces heart failure risk, supports cardiovascular health, and protects kidneys, offering reliable long-term diabetes and heart care.

Benefits of Empagliflozin (Jardiance)

• Controls blood sugar: Helps lower glucose levels by increasing sugar excretion through urine.
• Reduces heart failure risk: Supports cardiovascular health in diabetic patients.
• Aids in weight loss: Helps promote slight weight reduction in some patients.
• Protects kidneys: Lowers the risk of kidney complications in diabetes.

Patients take Jardiance once daily, often as part of a complete diabetes management plan.

Doctors prescribe Empagliflozin (Jardiance) – Diabetes/heart failure, commonly called Jardiance, to control type 2 diabetes while also promoting heart health. Moreover, it protects against cardiovascular issues and enhances long-term well-being.

Empagliflozin (Jardiance) provides dual benefits by managing diabetes and reducing heart failure risks for safer long-term health outcomes.

Empagliflozin (Jardiance) helps adults manage type 2 diabetes while supporting heart and kidney health, improving overall long-term wellness.